Glenmark Life Sciences IPO
Glenmark Life Sciences was founded in 2011 and is a leading manufacturer of active pharmaceutical ingredients (APIs). In a variety of therapeutic areas, the company develops and manufactures high-quality APIs for cardiovascular disease (CVD), neurological disease (CNS), pain management, and diabetes, gastroenteritis, antibiotics, and other pathways. In addition, it offers Contract Development and Manufacturing Operations (CDMO) to pharmaceutical companies.
A number of its products are sold in India and also exported to other countries. Japan, Europe, North America, Latin America, etc. The company has four manufacturing plants in Gujarat, one in Dahej in Gujarat, one in Mohol in Maharashtra, and one in Kurkumbh in Maharashtra with an aggregate installed capacity of 725.8 KL as of December 31, 2020.
Advantages in the marketplace:
- The leading manufacturer of selected specialized APIs for the treatment of CVS, CNS, diabetes, and pain.
- Export products to Europe, Latin America, North America, Japan, and the rest of the world.
- A strong relationship with leading global generics companies.
- Financial performance has been proven to be strong.
- A product-manufacturing infrastructure based on high-quality research and development.
Promoters of the company:
Glenmark Pharmaceuticals Limited is its promoter.
|Particulars||For the year/period ended (₹ in million)|
|Profit After Tax||2,468.97||3,130.98||1,955.92|
Glenmark Life Sciences IPO Details:
|IPO Opening Date||Jul 27, 2021|
|IPO Closing Date||Jul 29, 2021|
|Issue Type||Book Built Issue IPO|
|Face Value||₹2 per equity share|
|IPO Price||₹695 to ₹720 per equity share|
|Market Lot||20 Shares|
|Min Order Quantity||20 Shares|
|Listing At||BSE, NSE|
|Issue Size||[.] Eq Shares of ₹2|
(aggregating up to ₹1,513.60 Cr)
|Fresh Issue||[.] Equity Shares of ₹2|
(aggregating up to ₹1,160.00 Cr)
|Offer for Sale|
Objectives of the Issue:
- In connection with the spin-off of API business from the promoter to the company, to make payment of outstanding purchase considerations.
- Capital expenditures are required to be funded.
- In order to meet general corporate purposes.
Glenmark Life Sciences IPO Tentative Timetable:
The Glenmark Life Sciences IPO open date is Jul 27, 2021, and the close date is Jul 29, 2021. The issue may list on Aug 6, 2021.
|IPO Open Date||Jul 27, 2021|
|IPO Close Date||Jul 29, 2021|
|Basis of Allotment Date||Aug 3, 2021|
|Initiation of Refunds||Aug 4, 2021|
|Credit of Shares to Demat Account||Aug 5, 2021|
|IPO Listing Date||Aug 6, 2021|
Glenmark Life Sciences IPO Lead Manager(s)
- BoA Merrill Lynch
- BOB Capital Markets Limited
- DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
- Goldman Sachs (India) Securities Private Limited
- Kotak Mahindra Capital Company Limited
- SBI Capital Markets Limited
Lead Manager Reports
Glenmark Life Sciences IPO Lot Size:
The Glenmark Life Sciences IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹187,200).
Glenmark Life Sciences IPO Prospectus:
Company Contact Information:
Glenmark Life Sciences Limited
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213,
Phone: +91 2189 234456/ +91 2189
Glenmark Life Sciences IPO FAQs
Glenmark Life Sciences IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹1,513.60 Crores. The issue is priced at ₹695 to ₹720 per equity share. The minimum order quantity is 20 Shares.
The IPO opens on Jul 27, 2021, and closes on Jul 29, 2021.
KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Glenmark Life Sciences IPO opens on Jul 27, 2021 and closes on Jul 29, 2021.
Glenmark Life Sciences IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.
You can apply in Glenmark Life Sciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Glenmark Life Sciences IPO will be done on Aug 3, 2021, and the allotted shares will be credited to your demat account by Aug 5, 2021. Check the Glenmark Life Sciences IPO allotment status.
Also read- Tatva Chintan Pharma Chem IPO